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Abstract: Candida parapsilosis is among the most frequent causes of candidiasis. Clinical isolates
of this species show large variations in colony morphotype, ranging from round and smooth to a
variety of non-smooth irregular colony shapes. A non-smooth appearance is related to increased
formation of pseudohyphae, higher capacity to form biofilms on abiotic surfaces, and invading
agar. Here, we present a comprehensive study of the cell wall proteome of C. parapsilosis reference
strain CDC317 and seven clinical isolates under planktonic and sessile conditions. This analysis
resulted in the identification of 40 wall proteins, most of them homologs of known Candida albicans
cell wall proteins, such as Gas, Crh, Bgl2, Cht2, Ecm33, Sap, Sod, Plb, Pir, Pga30, Pga59, and adhesin
family members. Comparative analysis of exponentially growing and stationary phase planktonic
cultures of CDC317 at 30 ◦C and 37 ◦C revealed only minor variations. However, comparison of
smooth isolates to non-smooth isolates with high biofilm formation capacity showed an increase in
abundance and diversity of putative wall adhesins from Als, Iff/Hyr, and Hwp families in the latter.
This difference depended more strongly on strain phenotype than on the growth conditions, as it
was observed in planktonic as well as biofilm cells. Thus, in the set of isolates analyzed, the high
biofilm formation capacity of non-smooth C. parapsilosis isolates with elongated cellular phenotypes
correlates with the increased surface expression of putative wall adhesins in accordance with their
proposed cellular function.
Keywords: biofilm formation; adhesion; GPI; cell wall proteins; Als adhesins; Candida parapsilosis;
candidiasis
1. Introduction
Candida parapsilosis is a frequent cause of nosocomial and bloodstream infections,
especially in critically ill neonates and immunocompromised patients [1]. Premature infants
with a low birth weight are a principal risk group for acquiring C. parapsilosis infections
due to the requirement of parenteral nutrition using abiotic devices, such as indwelling
catheters [2]. This increases the probability of biofilm formation by this yeast, either alone
or in combination with other Candida species or nosocomial bacteria. Attachment onto
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and subsequent biofilm formation on medical materials often appears to be the source of
C. parapsilosis infections in patients in intensive care units or under surgical conditions [3–6].
Infections with multiple C. parapsilosis strains have also been reported [7]. Although biofilm
productivity has been reported for many C. parapsilosis sensu stricto isolates, data for the
related C. parapsilosis complex species Candida orthopsilosis and Candida metapsilosis are less
conclusive, and seem to depend on the tested surface material or strain background [8,9].
Biofilms are three-dimensional microbial communities encased in a matrix of ex-
tracellular polymeric substance (EPS), which provides protection against the activity of
antifungal compounds and the host immune system [10,11]. Biofilms on host tissues are
often the result of a complex interplay between multiple microbial inhabitants, such as
different Candida species and/or commensal bacteria. This may perhaps be different for abi-
otic surfaces, such as indwelling devices, if a contaminating organism has strong adherence
to a particular surface.
C. parapsilosis isolates have been shown to produce colonies with different shapes,
which roughly can be divided into smooth and various non-smooth morphotypes, such as
crepe and concentric. Most isolates present stable dominant phenotypes, but occasional
morphotype switching has been observed [12,13]. Furthermore, isolates with irregular
non-smooth morphotypes show elongated cellular morphologies (pseudohyphae) and
have a higher capacity to form biofilms [12,13].
The Candida cell wall is an essential organelle providing cellular strength and forming
a protective shield. It also plays a key role in host–pathogen interactions underlying the
establishment of fungal infections. These include attachment to host tissues, biofilm forma-
tion, invasion, host immune recognition, immune evasion, and proteolytic activities [14,15].
Studies using microscopy have shown that the wall of Candida has a bi-layered structure;
the inner layer is predominantly composed of a network of polysaccharides (β-glucans
and chitin), and is surrounded by a layer of mainly covalently-bound mannoproteins.
Known covalently-bound cell wall proteins (CWPs) are either connected to β-1,6-glucans
through a glycosylphosphatidylinositol (GPI) anchor remnant or bound to β-1,3-glucan
through a mild-alkali sensitive linkage (ASL). Functions of CWPs are manifold, ranging
from different families of carbohydrate-active enzymes involved in maturation of cell wall
glycans, adhesins, aspartic proteases, heme-iron utilizing proteins, superoxide dismutases,
phospholipases, and conserved families of proteins with still unknown or presumably
non-enzymatic functions [16]. Several studies have also mentioned wall-associated proteins
through disulfide bonds and proteins with known intracellular housekeeping functions, the
presence of which at the cell surface was explained to serve moonlighting functions [17].
Attachment of pathogenic Candida to abiotic surfaces or host tissues and cell aggre-
gation is mediated by cell wall adhesins. Described in Candida albicans are GPI-modified
adhesins of the Als, Hwp, and Iff/Hyr protein families [18], and members of all three
were found in cell wall preparations [16]. Most intensively studied are the Als proteins,
which bind to flexible C-termini of host surface proteins [19], and Hwp1, a hyphal-specific
protein that acts as a microbial substrate for epithelial cell transglutaminase to produce
cross-links with proteins on mammalian mucosa [20]. In the phylogenetically more dis-
tant yeast Candida glabrata, these adhesin families are not present; instead, it contains
several other families of putative GPI-modified adhesins [18], including well-described
Epa lectin-binding terminal galactose residues on host surface proteins [21,22].
Genomic studies have shown that the genome of C. parapsilosis encodes a similar
repertoire of putative GPI and other CWPs as C. albicans and related CTG-clade species,
including the same families of adhesins [23]. However, information about which proteins
are actually incorporated into the cell wall and are important for adhesion and biofilm
formation is limited. A shotgun proteomic study identified up to ten predicted C. parap-
silosis cell wall proteins in cultures that were induced to form pseudohyphae [24], while
phenotypic studies implicated a role for Als7 in adhesion to host extracellular matrix
proteins [25] and Rbt1 in biofilm formation [26].
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The aim of this study was to provide a comprehensive inventory of covalently-attached
cell wall proteins in C. parapsilosis, with a special focus on cell wall adhesins. First, the wall
proteome of reference strain CDC317, a poor biofilm producer, was characterized under
different planktonic conditions. Second, we compared the wall proteomes of smooth and
non-smooth isolates with different biofilm-formation capacities. Our results demonstrated
a strong increase of putative GPI-modified wall adhesins in isolates with non-smooth
morphotypes correlating with their high biofilm productivity, agar invasiveness, and
pseudohyphae formation.
2. Materials and Methods
2.1. Strains, Growth Conditions, and Biofilm Development
C. parapsilosis strains used in this study were part of a previously described strain
collection [12]. Strains were maintained on YPD (1% yeast extract, 2% peptone, and 2%
glucose) or Sabouraud (Oxoid GmbH, Wesel, Germany) agar. Colony morphology was
studied on YPD agar with or without 5 mg/mL of Phloxine B [13] (Sigma, Steinheim,
Germany) and on cornmeal agar [27] (Becton Dickinson and Company, Le-Pont de-Claix,
France). Inocula for liquid culturing were prepared by pre-culturing overnight in YPD,
unless stated otherwise. Liquid cultures for proteomic studies were grown at 30 or 37 ◦C
in YPD and harvested at the exponential phase (optical density (OD)600 = 1–2) or after
24 h of growth (stationary phase) by centrifugation. For the development of biofilms on
polystyrene, exponentially growing cultures in YPD were adjusted to OD600 = 1 with fresh
YPD. Twenty mL of the cell suspensions were seeded into sterile petri dishes and incubated
for 24 h at 37 ◦C in a moist environment. After incubation, unbound cells were removed,
and the biofilms were gently rinsed with mQ water. Bound cells were collected by scraping.
A similar procedure was used for the development of biofilms onto silicone elastomer.
In this case, sterile 25 cm2 non-reinforced silicone sheets (AMT Aromando Medizintechnik
GmbH, Düsseldorf, Germany) were deposited into petri dishes containing sterile glass
beads to prevent direct contact between the silicone and plastic. After incubation, the
sheets were rinsed and transferred to a new petri dish, and biofilm cells were collected by
scraping. For all proteomic samples, independent duplicate cultures were obtained and
analyzed separately.
2.2. Biofilm Formation onto Polystyrene and Silicone
Biofilm production of C. parapsilosis strains to plastic (polystyrene) was determined in
microtiter plates with the crystal violet (CV, Sigma) assay after 24 h of incubation in YPD at
37 ◦C in a moist environment, as detailed in [12].
For the determination of biofilm formation capacity onto silicone elastomers, overnight
pre-cultures were adjusted to a cell density of 0.8 McFarland, and 100 µL were added to
15 mL glass tubes containing 4 mL of YPD and a 1 cm2 silicone square. Cells and silicone
pieces were incubated overnight at 37 ◦C and 200 rpm. Silicone pieces were then removed
and deposited in a 12-well plate (Greiner Bio-One, Frickenhauser, Germany), and unbound
cells were washed off with phosphate-buffered saline (PBS). Washed silicone pieces were
transferred to wells of a new plate containing 1 mL of fresh PBS, biofilms were collected
by scraping the silicone surface, and cells were quantified by measuring the OD595 of a
1:100 dilution in PBS using an MRX-TC Revelation microplate reader (Dynex Technologies
GmbH, Denkendorf Germany).
2.3. Antifungal Susceptibility
Antifungal drug susceptibility was determined following EUCAST EDef 7.2 stan-
dards [28]. Amphotericin B (AMB), fluconazole (FLZ), posaconazole (POS), and voricona-
zole (VRZ) were obtained from Discovery Fine Chemicals Ltd. (Bournemouth, UK), caspo-
fungin (CAS) from Merck Sharp & Dohme Corp (MSD, Haar, Germany), and micafungin
(MFG) from Astellas. Minimum inhibitory concentration (MIC) values were determined
after 24 h at 37 ◦C.
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2.4. Agar Invasion Capacity
Agar invasion capacity of C. parapsilosis strains was tested as previously described
by [12,13]. Cells were plated on YPD agar supplemented with 5 mg/mL of Phloxine B
and allowed to grow for ten days. Agar invasion was scored by gently scraping colonies
with an inoculation loop while washing off the cells under running water at day ten of
incubation. Agar invasion was defined on a rating scale from low (1) to high (5) invasion
as described [12].
2.5. Microscopy
Colonies or biofilms in microplates prior to CV staining were observed through a
Zeiss Axiovert 200M microscope (Carl Zeiss AG, Oberkochen, Germany) at 10× and 40×
magnification. Cell morphology of overnight cultures in YPD was monitored by phase-
contrast microscopy. For the latter, cells were stained for 20 min with 0.1% Blankophor P
solution, washed with PBS, and fixed with 100% methanol for 5 min. After washing with
PBS, cells were embedded in Mowiol 4-88 (Sigma) and observed at 100× magnification.
2.6. Cell Wall Isolation
C. parapsilosis cell walls were purified following a previously described protocol [29–31].
Briefly, cells were disrupted with 0.4–0.6 mm glass beads (Sartorius, Goettingen, Germany)
in a Fastprep-24 machine (MP Biomedicals, Eschwege, Germany) during at least six runs
of 30 s at 6.5 m/s. Complete cell breakage was checked with a light microscope and,
if needed, additional runs were performed. After cell breakage, cell wall material was
washed extensively with 1 M of NaCl (each washing step in the protocol being followed by
centrifugation to pellet the cell wall material) and incubated twice for 10 min with sodium
dodecyl sulfate (SDS) extraction buffer (50 mM of Tris HCl, 2% SDS, 100 mM of Na-EDTA,
150 mM of NaCl, 0.8% β-mercaptoethanol, pH = 7.8) in a boiling water bath to remove any
non-covalently bound proteins. Finally, the walls were washed extensively with mQ water,
freeze-dried, and stored at −20 ◦C until use.
2.7. Mass Spectrometric Analysis
Reduction, S-alkylation, and proteolytic digestion of cell walls with Trypsin Gold
(Promega, Madrid, Spain) were performed as described [32]. Released peptides were
freeze-dried and taken up in 50% acetonitrile (ACN) and 2% formic acid. Peptide con-
centrations were estimated by measuring the OD214 and calibrating against a Peptide
Calibration Mixture (Thermo Scientific, Landsmeer, The Netherlands). Samples were di-
luted with a 0.1% trifluoroacetic acid (TFA) solution to reach a peptide concentration of
about 250–500 fmol µL−1. Samples were analyzed using an amaZon Speed Iontrap with a
CaptiveSpray ion source (Bruker, Leiderdorp, The Netherlands) coupled to an EASY-nLC II
(Proxeon, Thermo Scientific) chromatographic system. Peptide samples were injected and
separated with an eluent flow of 300 nL min−1 on an EASY Column of 10 cm (analytical
column SC200 coupled to a 2 cm trap column SC001 pre-column (Thermo Scientific)) using
a 50 min gradient of 0–50% ACN and 0.1% formic acid. Peptide precursor ions above a
predefined threshold ion count were selected for low-energy, collision-induced dissociation
(CID) to obtain fragmentation spectra of the peptides. The amount of sample used per run
was 0.5–1.0 pmol of peptide material.
2.8. MS/MS Database Searching
Raw MS/MS data were processed with Data Analysis software (Bruker, Billerica,
MA, USA). Resulting.mgf data files were used for searching with licensed Mascot soft-
ware (Version 2.5.1) against a non-redundant C. parapsilosis protein database prepared
with CDC317 protein sequences downloaded from NCBI. Simultaneously, searches were
performed against a common contaminants database (compiled by the Max Planck In-
stitute of Biochemistry, Martinsried, Germany) to minimize false identifications. Mascot
search parameters were: a fixed modification of carbamidomethylated cysteine, variable
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modification of oxidized methionine, trypsin with the allowance of one missed cleavage,
peptide charge state +1, +2, and +3, and decoy database activated. Peptide and MS/MS
mass error tolerances were 0.3 and 0.6 Da, respectively. Probability-based MASCOT scores
(http://www.matrixscience.com/, accessed on 15 February 2021) were used to evaluate
the protein identifications with a 1% false discovery rate as the output threshold. Peptides
with scores lower than 20 were ignored. Unmatched peptides were subjected to a second
Mascot search with semitrypsin as the protease setting, N/Q deamidation as the extra
variable modification, and a cutoff peptide ionscore of 40. Semitryptic peptides identified
in the second search served solely to extend the sequence coverage of proteins identified in
the first trypsin search. Protein identifications based on a single peptide match were only
taken into consideration if identified in multiples and at least one time in duplicate sam-
ples. The validity of single peptide matches was further verified by manual inspection of
MS/MS spectra in the raw data using the Data Analysis software. GPI protein predictions
were performed as described [33]. The total number of peptides (TP) identified for each
protein was determined by adding up all MS/MS fragmentation spectra, leading to protein
identification in the two duplicate samples.
3. Results
3.1. The Cell Wall Proteome of Reference Strain CDC317 under Planktonic Conditions
The first aim of this study was to obtain a comprehensive inventory of covalently-
bound cell wall proteins in the widely used C. parapsilosis reference strain CDC317. As this
strain is not a producer of thick biofilms, we applied planktonic conditions and compared
exponentially growing (OD600 = 1–2) and stationary phase (after 24 h of growth) cultures
in YPD, both at 30 ◦C and 37 ◦C. Our cell wall purification protocol included stringent
washing steps, removing non-covalently-bound proteins. The so-called cell-wall shaving
approach with trypsin was employed to release peptides from the purified wall matrices,
which subsequently were analyzed by tandem mass spectrometry (LC-MS/MS). Results
obtained with the reference strain are presented in Table 1; for mass spectrometric details
of individual peptides, see Supplementary Table S1. Each of the four conditions yielded
between 20 and 26 protein identifications, and a total of 27 wall proteins were identified
in CDC317. A majority of 18 proteins (Ywp1, Phr1, Phr2, Pga4, MP65, Bgl2, Crh11, Utr2,
Cht2, Plb5, Plb51, Rbt5, Ecm33, Pir1, Pga30, Pga59, Tos1, and Ssr1) were identified in all
four conditions, indicating little variation between the wall proteomes in these planktonic
cultures and good consistency of our data. A smaller set (Als6, Rbt1, Sod4, Sap9, Sap91,
Ecm331, Sun41, Rhd3, and Pga1) was not identified in all four conditions. Judged from
the total and different number of peptides identified for each protein (Table 1), these wall
proteins generally seemed to be less abundant. Thus, rather than regulatory issues, the
reason for their absence in any sample may be that the level of most of these proteins in the
wall is close to the lower detection limit of our instrumentation. Ecm331 and Sap91 may be
an exception to this. Sap91 was identified only—but with four different peptides—in cells
grown to the stationary phase at 37 ◦C. In this condition, Ecm331 showed higher peptide
counts and sequence coverage than in other conditions. Identified peptide counts further
suggested a higher abundance of Phr2, Ecm33, and Ssr1 in walls at 37 ◦C, especially at the
stationary phase. Consistent with this, all five proteins were also observed in all clinical
isolates grown under the same condition, as well as in biofilms (Tables 2 and 3).
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Table 1. MS/MS identification of cell wall proteins in C. parapsilosis CDC317.
CGD Name (Proposed Name) Ortholog (o) or Closest Homolog (h)
in C. albicans
Functional Class or Family Size (aa)
Exponential Growth Stationary Phase
30 ◦C 37 ◦C 30 ◦C 37 ◦C
Identified Peptides DP/TP a
Putative adhesins
CPAR2_404790 (Als6) Als6/C3_06190C (o) Als family 2392 1/2 1/1
Rbt1/CPAR2_403510 Rbt1/C4_03520C (o) Hwp family 812 1/2
Ywp1/CPAR2_806670 Ywp1/C2_08590W (o) Hwp family 522 1/86 1/73 1/72 2/100
Carbohydrate active enzymes
CPAR2_302140 (Phr1) Phr1/C4_04530C (o) CaZy GH72 Gas/Phr family 532 7/9 10/13 3/3 3/3
CPAR2_109660 (Phr2) Phr2/C1_00220W (o) CaZy GH72 Gas/Phr family 566 14/99 16/141 12/90 19/189
CPAR2_100110 (Pga4) Pga4/C5_05390C (o) CaZy GH72 Gas/Phr family 464 12/92 13/91 12/84 13/108
CPAR2_407410 (MP65) MP65/C2_10030C (o) CaZy GH17 Bgl2 family 372 12/75 12/96 9/45 12/77
CPAR2_401600 (Bgl2) Bgl2/C4_02250C (o) CaZy GH17 Bgl2 family 308 4/12 6/10 3/3 6/12
CPAR2_400860 (Crh11) Crh11/C4_02900C (o) CaZy GH16 Crh family 490 10/215 10/195 7/127 9/263
CPAR2_503190 (Utr2) Utr2/C3_01730C (o) CaZy GH16 Crh family 461 4/24 3/31 4/16 3/31
CPAR2_502140 (Cht2) Cht2/C5_04130C (o) CaZy GH18 Chitinase 584 28/604 34/506 24/393 24/326
Other enzymes
CPAR2_213080 (Sod4) Sod4/C2_00660C (o) Superoxide dismutase 215 1/1 1/2 1/3
CPAR2_102610 (Sap9) Sap9/C3_03870C (o) Aspartic protease 597 1/1 1/2 1/1
CPAR2_702730 (Sap91) Sap9/C3_03870C (h) Aspartic protease 528 4/7
CPAR2_804680 (Plb5) Plb5/C1_08230C (o) Phospholipase 724 5/10 6/19 6/12 7/37
CPAR2_808920 (Plb51) Plb5/C1_08230C (h) Phospholipase 884 5/23 8/27 6/27 11/70
Non-enzymatic or unknown function
CPAR2_402910 (Rbt51) Rbt5/C4_00130W (h) Iron acquisition Rbt5 family 232 1/24 1/25 1/3 1/45
CPAR2_108560 (Ecm33) Ecm33/C1_03190C (o) Ecm33 family 433 14/112 18/201 11/115 18/302
Ecm331/CPAR2_100710 Ecm331/C5_02460C (o) Ecm33 family 438 1/1 1/2 3/8
CPAR2_603090 (Sun41) Sun41/C6_00820W (o) Sun family 431 1/2
CPAR2_806490 (Pir1) Pir1/C2_08870C (o) Pir family 400 9/149 16/203 13/282 20/547
Pga30/CPAR2_402000 Pga30/C4_04070C (o) Pga30 family 285 5/9 2/8 11/60 8/19
Rhd3/CPAR2_402010 Rhd3/C4_04050C (o) Pga30 family 273 1/2 1/1
CPAR2_603340 (Pga59) Pga59/C4_02370C (o) Pga59/Pga62 family 138 1/9 1/12 1/5 1/8
CPAR2_503650 (Tos1) Tos1/C3_01550C (o) Unknown function 444 2/5 3/9 2/3 3/6
CPAR2_301540 (Ssr1) Ssr1/C7_00860W (o) Unknown function 241 11/133 13/213 10/144 14/258
CPAR2_200370 (Pga1) Pga1/CR_10480W (o) Unknown function 129 1/1 1/1 1/2
a DP, number of different peptides identified; TP, total number of peptides identified.
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b Cell Shape c
MIC (µg/mL) d
AMB FLZ POS VRZ CAS MFG
CDC317
(Ref. strain, skin) Smooth LBF
a 1 Yeast 0.125 4–16 0.125–0.25 0.125–0.25 1 1–2
PEU501




(Crepe) IBF 2 Yeast 0.125 0.5–1 0.063–0.125 0.031 0.5–1 2
PEU651
















(Smooth/concentric) HBF 5 Yeast & PH 0.125 1 0.125 0.031 2 2
a LBF, IBF, and HBF, low, intermediate, and high biofilm formation capacity, respectively. b Invasiveness ranges from low (1) to high (5). c Cellular morphology after overnight culturing in yeast extract,
peptone, dextrose (YPD), PH, pseudophyphae. d Minimal inhibitory concentrations (MICs) of amphotericin B (AMB), fluconazole (FLZ), posaconazole (POS), voriconazole (VRZ), caspofungin (CAS), and
micafungin (MFG).
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Table 3. Identified proteins in cell walls from C. parapsilosis clinical isolates.
Identified Protein
(Proposed Name)





PEU501 PEU582 PEU651 PEU486 PEU495 PEU496 PEU586
St a St/B_PS St/B_PS St/B_PS St/B_PS St/B_PS St/B_PS/B_S
Putative adhesins 117 b 68/90 33/27 564/525 433/484 592/582 466/698/509
CPAR2_404780 (Als11) Als1/C6_03700W (h) Als family SP, GPI + c +/+ −/− +/+ +/+ +/+ +/+/+
CPAR2_404790 (Als6) Als6/C3_06190C (o) Als family SP, GPI − +/+ −/− +/+ +/+ +/+ −/−/−
Als7/CPAR2_404800 Als7/C3_06320W (o) Als family SP, GPI + −/− −/− +/+ +/+ +/+ +/+/+
CPAR2_600430 (Hyr31) Hyr3/C5_00730W (h) Iff/Hyr family SP, GPI − −/− −/− −/+ −/− −/+ −/−/−
Rbt1/CPAR2_403510 Rbt1/C4_03520C (o) Hwp family SP, GPI + +/+ +/+ +/+ +/+ +/+ +/+/+
Ywp1/CPAR2_806670 Ywp1/C2_08590W (o) Hwp family SP, GPI + +/+ +/+ +/+ +/+ +/+ +/+/+
Non-adhesin proteins—core proteome 2206 2160/2000 2605/2261 1871/1550 1661/2139 1915/1693 1818/2046/2097
Carbohydrate active enzymes
CPAR2_302140 (Phr1) Phr1/C4_04530C (o) Gas/Phr family SP, GPI d + +/+ +/+ +/+ +/+ +/+ +/+/+
CPAR2_109660 (Phr2) Phr2/C1_00220W (o) Gas/Phr family SP, GPI + +/+ +/+ +/+ +/+ +/+ +/+/+
CPAR2_100110 (Pga4) Pga4/C5_05390C (o) Gas/Phr family SP, GPI + +/+ +/+ +/+ +/+ +/+ +/+/+
CPAR2_407410 (MP65) MP65/C2_10030C (o) Bgl2 family SP, ASL + +/+ +/+ +/+ +/+ +/+ +/+/+
CPAR2_401600 (Bgl2) Bgl2/C4_02250C (o) Bgl2 family SP, ASL + +/+ +/+ +/+ +/+ +/+ +/+/+
CPAR2_400860 (Crh11) Crh11/C4_02900C (o) Crh family SP, GPI + +/+ +/+ +/+ +/+ +/+ +/+/+
CPAR2_503190 (Utr2) Utr2/C3_01730C (o) Crh family SP, GPI + +/+ +/+ +/+ +/+ +/+ +/+/+
CPAR2_502140 (Cht2) Cht2/C5_04130C (o) Chitinase SP, GPI + +/+ +/+ +/+ +/+ +/+ +/+/+
CPAR2_502130 (Cht21) Cht2/C5_04130C (h) Chitinase SP, GPI − −/− −/− +/+ +/+ −/− +/+/+
CPAR2_502120 (Cht22) Cht2/C5_04130C (h) Chitinase SP, GPI − −/− −/− −/+ −/+ −/− −/−/+
Other enzymes
CPAR2_213080 (Sod4) Sod4/C2_00660C (o) Superoxide dismutase SP, GPI + −/− −/+ +/+ −/+ +/+ −/−/−
CPAR2_102610 (Sap9) Sap9/C3_03870C (o) Aspartic protease SP, GPI + −/+ +/+ −/+ −/+ +/+ +/+/+
CPAR2_702730 (Sap91) Sap9/C3_03870C (h) Aspartic protease SP, GPI + +/+ +/+ +/+ +/+ +/+ +/+/+
CPAR2_702720 (Sap92) Sap9/C3_03870C (h) Aspartic protease SP, GPI − +/+ +/+ +/+ −/− −/− −/−/−
CPAR2_500920 (Sap10) Sap10/C4_04470W (o) Aspartic protease SP, GPI − −/+ +/+ −/+ −/− −/− −/−/−
CPAR2_804680 (Plb5) Plb5/C1_08230C (o) Phospholipase SP, GPI + +/+ +/+ +/+ +/+ +/+ +/+/+
CPAR2_808920 (Plb51) Plb5/C1_08230C (h) Phospholipase SP, GPI + +/+ +/+ +/+ +/+ +/+ +/+/+









PEU501 PEU582 PEU651 PEU486 PEU495 PEU496 PEU586
St a St/B_PS St/B_PS St/B_PS St/B_PS St/B_PS St/B_PS/B_S
Non-enzymatic or Unknown function
CPAR2_402910 (Rbt51) Rbt5/C4_00130W (h) Rbt5 family SP c, GPI + +/+ +/+ +/+ +/+ +/+ +/+/+
CPAR2_300120 (Csa1) Csa1/C7_00090C (o) Rbt5 family SP, GPI − −/− −/− −/+ −/+ −/− +/+/+
CPAR2_108560 (Ecm33) Ecm33/C1_03190C (o) Ecm33 family SP, GPI + +/+ +/+ +/+ +/+ +/+ +/+/+
Ecm331/CPAR2_100710 Ecm331/C5_02460C (o) Ecm33 family SP, GPI + +/+ +/+ +/+ +/+ +/+ +/+/+
CPAR2_603090 (Sun41) Sun41/C6_00820W (o) Sun family SP, ASL − +/+ −/− +/− −/− −/− −/−/−
CPAR2_806490 (Pir1) Pir1/C2_08870C (o) Pir family SP, 8 Pir repeats, ASL + +/+ +/+ +/+ +/+ +/+ +/+/+
Pga30/CPAR2_402000 Pga30/C4_04070C (o) Pga30 family SP, GPI + +/+ +/+ +/+ +/+ +/+ +/+/+
Rhd3/CPAR2_402010 Rhd3/C4_04050C (o) Pga30 family SP, GPI − +/+ +/+ −/− −/− −/− −/−/−
CPAR2_603340 (Pga59) Pga59/C4_02370C (o) Pga59/Pga62 family SP, GPI + −/− −/− −/− +/+ +/+ −/−/−
CPAR2_503650 (Tos1) Tos1/C3_01550C (o) Unknown function SP, ASL + +/− +/− +/− +/+ +/+ +/−/+
CPAR2_301540 (Ssr1) Ssr1/C7_00860W (o) Unknown function SP, GPI + +/+ +/+ +/+ +/+ +/+ +/+/+
CPAR2_200370 (Pga1) Pga1/CR_10480W (o) Unknown function SP, GPI − −/− −/− +/− +/− +/− −/−/−
CPAR2_400900 (Pga53) Pga53/C4_01360W (o) Unknown function SP, GPI + −/− −/− −/+ −/− +/+ −/−/−
CPAR2_701390 No hits Unknown function SP, GPI − +/+ +/+ −/+ −/− −/− −/−/+
CPAR2_805040 C1_10170W (o) Unknown function SP − −/− +/+ −/− −/− −/− −/+/+
CPAR2_403880 No hits Unknown function SP − +/+ −/− −/− −/− −/− −/−/−
CPAR2_405510 (Nce102) NCE102/C3_04910C (o) Unknown function SP − −/− −/− −/− −/− −/− +/+/+
a St, Stationary phase; B_PS, polystyrol biofilm; B_S, silicone biofilm. b Total number of adhesin or non-adhesin peptides identified. c Protein identified (+) or not identified (−) in the sample. d Unclear GPI
prediction for CPAR2_302140; CPAR2_402910 seemed to lack N-terminal ~23 aa.
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3.2. Selection and Characteristics of C. parapsilosis Isolates with Different Biofilm
Formation Status
Only a few peptides from proteins belonging to Als and Hwp adhesin families were
identified in the low biofilm-forming (LBF) reference strain CDC317, while peptides from
Iff/Hyr proteins were absent (Table 1). In C. glabrata, the incorporation of putative adhesins
was shown to depend on the adhesion/biofilm formation capacity of clinical isolates [31].
This prompted us to investigate if this was also the case in C. parapsilosis. Therefore, the
second aim of this study was to compare the wall proteomes of strains with different
capacities to form biofilms.
Seven C. parapsilosis clinical isolates with either low (LBF; OD595 < 0.08), intermediate
(IBF; 0.2–0.3), or high (HBF; > 0.4) biofilm formation capacity on polystyrene and represen-
tative and stable morphotypes were selected from a previously described collection [12].
Among these selected strains, the four HBF isolates were the only strains that also formed
considerable biofilms on silicone elastomers, PEU586 showing the highest level (Figure 1).
The dominant morphotype of HBF strains was non-smooth crepe versus smooth for the
selected LBF and IBF strains (Table 2 and Figure 2). The HBF strains also showed higher
agar invasion and more frequent appearance of elongated pseudohyphae compared to the
LBF and IBF isolates. In contrast, no obvious correlation between biofilm formation status
and antifungal drug susceptibility profiles or clinical origin of these isolates was detected
(Table 2), in line with the data for the whole strain collection [12]
Figure 1. Biofilm formation onto polystyrene and silicone. The quantity of cell material that adhered
to polystyrene (PS) or silicone after 24 h of incubation in YPD at 37 ◦C was determined as detailed
in the Materials and Methods section. Data shown are averages ± SDs of at least two independent
biological experiments with four technical replicates each. Photographs below show the dominant
colony morphotype of each strain after 96 h of growth on YPD agar at 37 ◦C.
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Figure 2. Colony morphotype and cellular morphology of LBF, IBF, and HBF strains. (A) Predominant
colony morphotypes on YPD + phloxine B agar after 96 h of growth. (B) Borders of colonies grown on
YPD agar for 96 h. (C,D) Colonies grown on cornmeal agar for 48 h (C) and 96 h (D). (E) Cells/biofilms
adhered to polystyrene after 24 h of incubation. (F) Cellular morphology after overnight culturing in
liquid YPD observed by phase-contrast microscopy.
Proteomic analysis of IBF and HBF strains was performed with walls isolated from
24 h biofilms on polystyrene (Table 3). The growth of a sufficient biofilm for wall isolation
and proteomic analysis on silicone was more difficult, therefore, this was performed only
with the strongest silicone biofilm-producing strain, PEU586. LBF strain PEU501, like
CDC317, hardly developed biofilms on any surface. For comparative reasons, all strains
were therefore also analyzed under planktonic conditions by culturing to the stationary
phase at 37 ◦C.
3.3. The Core Cell Wall Proteome of C. parapsilosis
Analysis of the proteomic data of the seven C. parapsilosis clinical isolates confirmed and
completed the image of the wall proteome obtained by analysis of CDC317. All 27 proteins
identified in strain CDC317 were also identified in at least two of the clinical isolates,
and a total of 40 proteins were identified (Table 3, see Supplementary Table S1 for mass
spectrometric details of individual peptides). Of the 18 proteins that were identified in
all four CDC317 culturing conditions, only Pga59 was not identified in all seven clinical
isolates. These ubiquitous proteins therefore can be considered a part of the core cell wall
proteome of C. parapsilosis.
All 40 identified proteins were classical secretory proteins with N-terminal signal
peptides, and 37 also carried C-terminal GPI-anchoring signals or, by analogy to C. albi-
cans, belonged to families of ASL wall proteins [34]. Thirty-four proteins were orthologs
or closest homologs of proteins that have also been identified in wall proteomic stud-
ies of C. albicans [16]. Of the remaining six proteins, three were predicted GPI proteins:
Pga1 and Pga53 were orthologs of C. albicans GPI proteins with unknown function, and
CPAR2_701390 also was a protein with unknown function, for which NCBI Blast did not
reveal homologs in other Candida spp., except for an ortholog in the closely related C. orthop-
silosis. CPAR2_701390 showed 32% sequence identity with adjacent ORF CPAR2_701380,
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another predicted GPI protein. Interestingly, these two proteins shared a conserved pat-
tern of eight cysteine residues in their N-terminal parts reminiscent of, but not identical
to, CFEM domains [35] that are present in Rbt5 family proteins and Ssr1. The last three
identified proteins, Nce102, CPAR2_805040, and CPAR2_403880, were secretory proteins of
unknown function lacking predicted GPI anchoring signals, which made their presence
among covalently-bound proteins surprising. For all three proteins, their identification was
based on a single peptide match that was found in planktonic as well as biofilm samples of
only one or two of the clinical isolates. Other proteins identified in clinical isolates but not
in CDC317 were the putative adhesins Als7, Als11, and Hyr31, the Cht2 chitinase homologs
Cht21 and Cht22, the aspartic proteases Sap10 and Sap92, and the Rbt5 family protein
Csa1, Pga53, and CPAR2_701390. Of these, Hyr31, Cht21, Cht22, Csa1, and Nce102 were
identified in HBF strains only. On the contrary, Rhd3 was the only protein that was not
identified in any of the HBF strains.
Comparison of cell wall proteomes in biofilms versus planktonic conditions yielded
only some minor proteomic differences (Table 3). Hyr31 and Cht22 were detected only in
biofilm samples, while Pga1 was detected only in planktonic conditions. Similar to the
above explanation for possible differences among CDC317 samples, a generally low abun-
dance of these three proteins (judged from peptide counts, Supplementary Table S2) with
rather differential regulation may perhaps explain their identification in only few samples.
3.4. Incorporation of Wall Adhesins Is Increased in C. parapsilosis Isolates with High
Biofilm-Formation Capacity
When the proteomic data of the different clinical isolates were analyzed in a semi-
quantitative manner by peptide counting (Table 3 and Supplementary Table S2), a very
notable difference was observed between HBF isolates and LBF + IBF isolates in the number
of different (DP) and total (TP) peptides identified for members of Als, Hwp, and Iff/Hyr
putative adhesin families. In 37 ◦C stationary phase planktonic samples of LBF and IBF
strains, the DP for such proteins varied from 3–10, and the TP from 33–117. In the two
IBF biofilm samples, the DP for putative adhesins was 3–14, with 212–213 TP identified.
However, in HBF strains, the number of putative adhesin peptides was much higher:
39–51 DP and 433–592 TP in 37 ◦C stationary phase planktonic samples, and 43–50 DP
and 484–698 TP in biofilm samples. With the calculated average DP and TP for both
groups of strains, one can infer that, in the HBF strains, putative adhesins were 8.1 (DP) to
6.4 (TP) times more abundant in planktonic and 5.6 (DP) to 9.6 (TP) times more abundant
in biofilm cultures compared to LBF/IBF strains. In contrast to this higher abundance
of putative adhesin peptides in HBF strains, the average numbers of all identified wall
peptides were almost identical in the two groups, with HBF/(LBF + IBF) ratios of 1.08 for
average DP and 1.03 for average TP. Thus, our analysis clearly showed upregulation of
putative adhesins in HBF strains, which seems to be five- to tenfold higher under both
planktonic and biofilm conditions.
A total of six different putative adhesins were identified in the walls of HBF strains:
in addition to Als6, Rbt1, and Ywp1, which were also found in CDC317, Als proteins
Als7 and Als11 and Iff/Hyr family protein Hyr31 were identified. Based on DP and TP
counts, the two Als proteins appeared strongly upregulated in HBF strains, and this was
also the case for Rbt1. Hyr31 was only detected in HBF strains, thus, its expression may
also be related to biofilm formation capacity; however, the low peptide coverage of this
protein did not allow hard conclusions, as commented above. Ywp1, on the other hand,
appeared to be most abundant in the two LBF strains PEU501 and CDC317 (under all four
planktonic conditions analyzed). This was remarkable for a protein from an adhesin family,
as discussed below.
Finally, the wall proteome of PEU586 biofilms grown on silicone was almost identical
to biofilms on polystyrene and planktonic stationary phase cultures, and no differential
incorporation of putative adhesins was observed. Surprisingly, adhesin Als6 was absent in
all samples of this HBF strain.
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4. Discussion
Here, we have presented a comprehensive study of the covalently-bound cell wall
proteome in C. parapsilosis. Our study compiles data from eight different strains with
different capacities to form biofilms. Analyzed culturing conditions include planktonic
exponentially growing and stationary phase cultures at both 30 and 37 degrees, as well
as biofilm cultures on polystyrene and silicone. The retention of non-covalently bound
or moonlighting proteins was avoided by executing stringent washing steps during the
cell wall isolation procedure. In the past, we have applied this procedure successfully
to various other fungal species, including the related yeasts C. albicans, C. glabrata, and
Saccharomyces cerevisiae, as well as the filamentous Aspergillus nidulans [29,31,32,36]. The
analyzed C. parapsilosis samples yielded a total of 40 identifiable wall proteins, including
all genuine wall proteins identified by Karkowska-Kuleta and colleagues [24].
Sequences of all identified proteins contain canonical signal peptides for secretion,
and are thus destined to reach the cell surface. Most are homologs of C. albicans proteins
that have previously been identified in cell wall preparations and/or are predicted GPI
proteins. The only three exceptions to this are Nce102, CPAR2_805040, and CPAR2_403880.
All different classes or families of wall proteins known from C. albicans are represented in
our list, including Als, Hwp, and Iff/Hyr putative adhesins, Gas/Phr, Bgl2, Crh, and Cht2
glycoside hydrolyases with diverse functions in modification or crosslinking of cell wall
polysaccharides during growth and division, aspartic proteases with proposed roles in the
shedding of wall proteins and host tissue invasion, phospholipases, Ecm33, Rbt5, Pga30,
Pga59, and Sun41 family proteins, superoxide dismutase Sod4, and a Pir protein with a
proposed non-enzymatic role in β-1,3-glucan crosslinking [16].
Explaining why Nce102, CPAR2_805040, and CPAR2_403880 are encountered among
covalently-bound wall proteins is challenging. It may be that they belong to the class
of alkali-extractable ASL proteins. For the best-studied ASL wall protein in S. cerevisiae,
Cis3/Pir4, it has been shown that a conserved glutamine-rich repeat sequence (Pir repeat)
is essential for forming a covalent link to cell wall β-1,3-glucan [37]. However, various
other ASL proteins or ASL protein homologs in S. cerevisiae, C. albicans, and C. glabrata
do not contain such Pir repeats, and the nature of their alkali-sensitive linkages remains
poorly understood to date. Another possibility is that the three proteins are strongly
associated to the cell wall matrix in a different way, perhaps even non-covalently. The
three proteins were mass spectrometrically identified by a single peptide and only in one
or two clinical isolates, indicating a low overall abundance in our samples. It is noteworthy
that the C. albicans orthologs of Nce102 and CPAR2_805040 have been reported to be
upregulated in biofilms [38,39], and the latter has putative adhesin properties, according
to the FungalRV predictor [40]. We did not attempt protein extractions with mild alkali
to investigate the issue in more detail, as we consider this beyond the scope of this wall
proteomic shotgun study.
Various studies have reported considerable dynamics of the wall proteome in C. albi-
cans when altering growth conditions, such as pH [41], carbon source [42], the presence of
fluconazole in the growth medium [43], or conditions that induce hyphal formation [44].
The latter triggers specific expression of various wall proteins, for instance the adhesins
Als3, Hwp1, and Hyr1, and the superoxide dismutase Sod5, while some other proteins
(Rhd3, Sod4, and Ywp1) showed decreased levels in the walls of hyphae. Our study in
C. parapsilosis did not show major intra-strain, growth condition-dependent, wall protein
dynamics, neither when comparing different planktonic growth conditions for CDC317
(exponential growth versus stationary phase at 30 ◦C and 37 ◦C) nor when comparing
planktonic cultures and biofilms for six IBF and HBF clinical isolates. In contrast, clear
changes in the wall proteome of C. parapsilosis were observed depending on the biofilm-
forming capacity of the different clinical isolates analyzed, as discussed below. We propose
that the constitutively observed proteins, that is, the ones that were detected in most
isolates and under most conditions and that generally yielded the highest peptide counts,
constitute the core cell wall proteome of C. parapsilosis.
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The pathogenicity of C. parapsilosis is related to its ability to adhere to host tissues and
to form a biofilm on medical devices governed by proteins with adhesive functions [5].
C. parapsilosis contains the same families of putative adhesins as C. albicans and other
CTG-clade Candida species [23]. Comparison of adhesive capacity to buccal epithelial
cells (BECs) or acrylic surfaces of various C. albicans and C. parapsilosis clinical isolates
did not reveal significant differences between the two organisms [45]. In the same study,
higher adhesion to BECs was reported for superficial isolates than for systemic isolates of
C. parapsilosis [45]. In our strain collection, no relation between biofilm-forming capacity
and the host site of infection was detected nor any relation between biofilm-forming
capacity and antifungal drug susceptibility [31]. However, in accordance with earlier
studies, HBF phenotypes in our collection correlate with the appearance of non-smooth
colonies, increased pseudohyphae formation, and high agar invasion capacity [12,13,46,47];
this is also the case for the HBF representatives used in this study that originated from ear
and nose swabs (2x), skin, and urine samples.
Similar to our earlier studies with hyperadhesive strains in C. glabrata [31], the four
HBF isolates showed increased incorporation of putative adhesins compared to LBF and
IBF isolates. While few peptides from putative adhesins of Als, Hwp, or Iff/Hyr families
were identified in LBF and IBF strains, a clear five- to tenfold increase in the number of
peptides originating from these protein families was detected in HBF strains. C. glabrata is
phylogenetically more distant to C. parapsilosis and C. albicans, and does not contain Als,
Hwp, or Iff/Hyr families. Instead, it contains different families of adhesins, for instance,
Epa proteins that act as lectins to make connections with host epithelia [21,22], as well as
many other putative GPI-modified adhesins, the functions of which are still uncovered [48].
Two recent studies reported on C. parapsilosis ALS gene expression using real-time
PCR [49] or RNAseq analysis [50] of strains with different adhesive capacity under adhesion-
inducing as well as non-inducing conditions. Both studies suggest that, despite some
observed upregulation of ALS7/CPAR2_404800 in one strain under adhesion-inducing
conditions [50], the regulation of ALS genes depended more on phenotypic strain vari-
ability than on growth conditions. Our data concur with this view, and indicate that this
is also the case for the Hwp and Hyr adhesin families. However, detailed analysis of
genomic variations that may lead to altered adhesin expression will have to await the
availability of sequence information of isolates with different biofilm formation capaci-
ties. Als6/CPAR2_404790 has been reported as the most highly expressed Als protein [49],
but, strikingly, this protein was absent in the walls of HBF strain PEU586. Therefore, the
high adhesive capacity of this strain to silicone elastomer does not seem to be related to
Als6 expression.
The levels of Als7, Als11, and Rbt1 were especially highly upregulated in HBF strains.
This also seems to be the case for Hyr31, although most of its identified peptides are
non-unique and shared by multiple Iff/Hyr family members. For Als7 and Rbt1, our data
concur with phenotypic studies that demonstrated their involvement in adhesion to ECM
proteins [25] and biofilm formation [26], respectively. Ywp1 presents a special case. Its
ortholog in C. albicans has been categorized as a putative Hwp-like adhesion, because it
contains repeat motifs that are characteristic for this protein family [18]. However, the
protein is decreased in hyphae, unlike several adhesins, and C. albicans mutants deficient
in Ywp1 showed increased adhesiveness and biofilm formation. Therefore, rather than
acting as an adhesin, Ywp1 was proposed to have anti-adhesive properties and promote
the dispersal of yeast cells [51]. This view is consistent with our data, showing that Ywp1
was most abundant in the two LBF strains.
In conclusion, this study provides a detailed inventory of covalently-associated wall
proteins in the pathogenic yeast C. parapsilosis. The C. parapsilosis wall proteome comprises
a stable set of core proteins, including all functions that are required for proper wall
synthesis and functioning, supplemented by proteins with putative adhesive functions.
Non-smooth HBF strains show increased incorporation of putative adhesins, correlating
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with the higher capacity of these strains to adhere, form biofilm, develop pseudohyphae,
and invade agar.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/pathogens10040493/s1, Table S1: MS/MS identification of cell wall proteins in C. para-
psilosis, Table S2: Semi-quantitative peptide counting of CW proteomic data from C. parapsilosis
clinical isolates.
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